Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?. // Journal of the American Society of Cytopathology. – URL: https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all
Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?. Journal of the American Society of Cytopathology. https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all
“Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?.” Journal of the American Society of Cytopathology.
@article{article31316,
title = {Does Afirma Molecular Testing Reduce Surgery Rates and Improve Management Appropriateness in Bethesda III–IV Thyroid Nodules?},
journal = {Journal of the American Society of Cytopathology},
url = {https://www.sciencedirect.com/science/article/pii/S2213294526002152?dgcid=rss_sd_all}
}